AMRI co-founder on pharmacy school’s board

Thomas D’Ambra, who cofounded Albany Molecular Research Inc., has been appointed to the board of trustees at Albany College of Pharmacy and Health Sciences. D’Ambra, currently chairman of the board at AMRI, retired as CEO last year.

AMRI and D’Ambra developed the active ingredient in the allergy medicine Allegra. AMRI, based in Albany, also has locations in Europe and Asia.

“As he demonstrated so clearly with AMRI, Tom is a talented chemist, innovator, entrepreneur, and businessman,” said Gregory Dewey, president of Albany College of Pharmacy and Health Sciences. “Both the Board of Trustees and the College will benefit greatly from his knowledge and expertise. We are excited to welcome him as a trustee.”